Briefly, during follow‐up, the survival rate of the high GPX4 expression group was consistently lower than that of the low GPX4 expression group, suggesting that high GPX4 expression was significantly correlated with shorter overall survival (OS) of patients with CRC (Figure S2D, Supporting Information). Here, GPX4 is linked to colorectal carcinoma.